Junipro Sabor Fresa (Ibuprofen)

Ibuprofen works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This reduces the synthesis of prostaglandins, which are chemicals that mediate pain, fever, and inflammation. Lower prostaglandin levels lead to decreased peripheral sensitisation and a reduced febrile response.

The appropriate dose of Junipro Sabor Fresa is set by the prescribing health‑care professional based on the patient’s age, weight, clinical condition, and any relevant comorbidities. Dosage may differ for acute pain, chronic inflammatory disorders, or fever management, and should follow the prescriber’s instructions.

Ibuprofen is generally avoided in the third trimester of pregnancy because it may affect fetal cardiovascular development. Use during the first two trimesters should only occur if clearly needed and prescribed. Limited data exist for breastfeeding, but small amounts pass into milk; a health‑care provider should assess risk versus benefit.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Both ibuprofen (Junipro Sabor Fresa) and naproxen belong to the NSAID class and share similar mechanisms of COX inhibition. Ibuprofen has a shorter half‑life, often requiring multiple daily doses, whereas naproxen provides longer‑lasting relief with fewer doses. Individual response, safety profile, and specific clinical guidelines guide the choice between them.

Store Junipro Sabor Fresa at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight, and extreme heat. Do not use if the packaging is damaged or if the tablet shows signs of discoloration.

Junipro Sabor Fresa is taken orally, usually with a glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. The exact timing and frequency should follow the prescribing clinician’s directions.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, hepatotoxicity, and increased cardiovascular events like heart attack or stroke, especially with long‑term or high‑dose use. Patients should seek immediate medical attention if they notice black stools, severe abdominal pain, swelling, or breathing difficulties.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe renal or hepatic disease, uncontrolled hypertension, or in the third trimester of pregnancy should avoid Junipro Sabor Fresa. A health‑care professional should evaluate any other underlying conditions before prescribing.